Orion Infusion Statistics

Total Valuation

Orion Infusion has a market cap or net worth of BDT 8.10 billion. The enterprise value is 8.39 billion.

Market Cap	8.10B
Enterprise Value	8.39B

Important Dates

The next estimated earnings date is Wednesday, January 29, 2025.

Earnings Date	Jan 29, 2025
Ex-Dividend Date	Dec 5, 2024

Share Statistics

Orion Infusion has 20.36 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	20.36M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	18.85%
Owned by Institutions (%)	n/a
Float	3.82M

Valuation Ratios

The trailing PE ratio is 202.65.

PE Ratio	202.65
Forward PE	n/a
PS Ratio	10.25
PB Ratio	24.88
P/TBV Ratio	24.88
P/FCF Ratio	173.68
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 80.92, with an EV/FCF ratio of 179.90.

EV / Earnings	209.91
EV / Sales	10.62
EV / EBITDA	80.92
EV / EBIT	100.54
EV / FCF	179.90

Financial Position

The company has a current ratio of 0.93, with a Debt / Equity ratio of 0.97.

Current Ratio	0.93
Quick Ratio	0.39
Debt / Equity	0.97
Debt / EBITDA	3.05
Debt / FCF	6.78
Interest Coverage	2.36

Financial Efficiency

Return on equity (ROE) is 12.69% and return on invested capital (ROIC) is 8.00%.

Return on Equity (ROE)	12.69%
Return on Assets (ROA)	6.30%
Return on Capital (ROIC)	8.00%
Revenue Per Employee	1.10M
Profits Per Employee	55,664
Employee Count	718
Asset Turnover	0.96
Inventory Turnover	4.19

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +6.62% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+6.62%
50-Day Moving Average	305.71
200-Day Moving Average	461.36
Relative Strength Index (RSI)	71.92
Average Volume (20 Days)	251,354

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Orion Infusion had revenue of BDT 790.20 million and earned 39.97 million in profits. Earnings per share was 1.96.

Revenue	790.20M
Gross Profit	323.69M
Operating Income	83.44M
Pretax Income	47.72M
Net Income	39.97M
EBITDA	96.04M
EBIT	83.44M
Earnings Per Share (EPS)	1.96

Full Income Statement

Balance Sheet

The company has 20.69 million in cash and 316.28 million in debt, giving a net cash position of -290.11 million or -14.25 per share.

Cash & Cash Equivalents	20.69M
Total Debt	316.28M
Net Cash	-290.11M
Net Cash Per Share	-14.25
Equity (Book Value)	325.59M
Book Value Per Share	15.99
Working Capital	-33.38M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 59.83 million and capital expenditures -13.20 million, giving a free cash flow of 46.63 million.

Operating Cash Flow	59.83M
Capital Expenditures	-13.20M
Free Cash Flow	46.63M
FCF Per Share	2.29

Full Cash Flow Statement

Margins

Gross margin is 40.96%, with operating and profit margins of 10.56% and 5.06%.

Gross Margin	40.96%
Operating Margin	10.56%
Pretax Margin	6.04%
Profit Margin	5.06%
EBITDA Margin	12.15%
EBIT Margin	10.56%
FCF Margin	5.90%

Dividends & Yields

This stock pays an annual dividend of 1.20, which amounts to a dividend yield of 0.30%.

Dividend Per Share	1.20
Dividend Yield	0.30%
Dividend Growth (YoY)	20.00%
Years of Dividend Growth	n/a
Payout Ratio	44.72%
Buyback Yield	n/a
Shareholder Yield	0.30%
Earnings Yield	0.49%
FCF Yield	0.58%

Dividend Details

Stock Splits

The last stock split was on December 4, 2011. It was a forward split with a ratio of 10.

Last Split Date	Dec 4, 2011
Split Type	Forward
Split Ratio	10

Scores

Orion Infusion has an Altman Z-Score of 12.59.

Altman Z-Score	12.59
Piotroski F-Score	n/a